All Vaccinology articles
-
NewsInstitut Pasteur issues statement on U.S. administration’s attacks against biomedical research, global public health action and vaccination
For several months now, the current U.S. administration has consistently attacked and endeavored to weaken biomedical research and public health action in the United States and worldwide with unparalleled vigor, the Institut Pasteur has said in a new statement.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
NewsNew platform could develop vaccines faster than ever before
Scientists are optimizing a vaccine-development platform created to accelerate how quickly life-saving vaccines can be designed and deployed during infectious-disease outbreaks such as the COVID-19 pandemic.
-
NewsPreparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response
A new study has shown for the first time that an experimental vaccine against Middle East Respiratory Syndrome (MERS) induces a stable and functional immune response in humans that persists for at least two years after a booster vaccination.
-
News‘Nudging’ both patients and providers boosts flu vaccine numbers
Patients were 28 per cent more likely to get a flu shot when they got a text message reminder and their primary care provider already had an order for the shot waiting, new research showed.
-
NewsScientists develop novel live-attenuated vaccine that blocks coronavirus transmission with a single intranasal dose
A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. Source: NIAID-RML This colorized transmission electron microscope image shows ...
-
NewsMost would recommend RSV immunizations for older and pregnant people
A US survey found an increase in awareness of immunizations that are available for RSV. The survey of 1,637 U.S. adults also found that about 6 in 10 respondents would recommend the vaccine or antibody injections to the groups recommended by the CDC, an increase from past years.
-
NewsGlobal Virus Network warns of measles resurgence
The Global Virus Network (GVN) has expressed deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children.
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsShingles vaccine linked to slower biological aging in older adults
Shingles vaccination not only protects against the disease but may also contribute to slower biological aging in older adults, according to a new study.
-
NewsProject to combat childhood diarrhea receives over 5 million euros
A new project will use probiotics, improved education in hygiene and advanced mathematical models to prevent children from dying of diarrhea in low and middle-income countries.
-
NewsVaccine against foot-and-mouth disease could deliver $1.3 billion a year in global livestock benefits
A new foot-and-mouth disease vaccine is projected to deliver over $1.3 billion in annual benefits and transform global livestock resilience.
-
NewsUK: COVID-19 vaccine hesitancy decreased over time, though mistrust persists among certain groups
Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a new study following more than 1.1 million people in England between January 2021 and March 2022 during the COVID-19 pandemic.
-
NewsWhooping cough vaccination for pregnant women strengthens babies’ immune system
Vaccinating women during pregnancy leads to the transfer of antibodies to their newborns. These antibodies were detected not only in blood, but also in the nasal mucosa, the site where whooping cough bacteria enter the body.
-
NewsCholera vaccine completes phase 1 trial
A clinical trial shows promising results for PanChol, a single-dose oral vaccine aimed at the up to 4 million annual cholera cases worldwide.
-
NewsStudy reveals low immunity against H3N2 strain in Hong Kong; early vaccination urged
Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as ‘subclade K’. Researchers have found that most hospital patients in Hong Kong have little to undetectable levels of neutralising antibodies against this mutated strain.
-
NewsCytomegalovirus breakthrough could lead to new treatments
Researchers have developed a new type of antibody with a modified structure that can outsmart cytomegalovirus and neutralize its ability to evade the immune system.
-
NewsSilent dengue infections may hold clues to future vaccine design, study finds
Researchers report the first single-cell immune atlas of asymptomatic dengue, offering a rare look at how the immune system can defeat the virus without triggering illness. The work could help guide the design of safer and more effective dengue vaccines.
-
NewsAs US measles cases rise, views of MMR vaccine safety and effectiveness – and willingness to recommend it – drop
As U.S. measles cases rise, a new nationally representative panel survey finds a small but significant drop in the proportion of the public that would recommend that someone in their household get the MMR vaccine, which protects against measles, mumps, and rubella.
-
NewsCOVID-19 vaccination significantly reduces risk to pregnant women and baby
Pregnant women who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new study.